| Cash Flow | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
|---|---|---|---|---|
| Lease termination | NaN | 0 | 0 | 0 |
| Distributions from equity method investments | NaN | 439 | 147 | 3,492 |
| Net income (loss) | 6,151 | 33,852 | 31,341 | 70,795 |
| Depreciation expense, intangible asset and other amortization | 17,670 | 15,543 | 16,184 | 31,896 |
| Stock-based compensation | 5,189 | 4,733 | 5,688 | 13,543 |
| Equity in earnings of equity method investments | 1,073 | 937 | 571 | 2,127 |
| Realized and unrealized (gains) losses on investments of cip, net-Consolidated Entity Excluding Variable Interest Entities VIEand Voting Interest Entities VOE | 814 | -1,024 | 2,251 | 2,987 |
| Change in fair value of contingent consideration | 409 | 800 | 0 | -3,014 |
| Deferred taxes, net | 1,397 | 1,900 | 3,067 | 3,434 |
| Sales (purchases) of investments, net | 15,891 | 22,268 | -25,693 | 3,834 |
| Accounts receivable, net and other assets | -5,126 | -8,028 | -4,736 | -9,460 |
| Accrued compensation and benefits, accounts payable, accrued liabilities and other liabilities | -107,160 | 38,263 | 42,181 | -103,610 |
| Realized and unrealized (gains) losses on investments of cip, net-Variable Interest Entity Primary Beneficiaryand Voting Interest Entity | -13,037 | 1,567 | -13,028 | -6,903 |
| Purchases of investments by cip-Variable Interest Entity Primary Beneficiaryand Voting Interest Entity | 312,406 | 647,604 | 261,039 | 538,448 |
| Sales of investments by cip-Variable Interest Entity Primary Beneficiaryand Voting Interest Entity | 388,968 | 269,702 | 279,826 | 581,278 |
| Net proceeds (purchases) of short-term investments and securities sold short by cip-Variable Interest Entity Primary Beneficiaryand Voting Interest Entity | -83 | -82 | 8 | -120 |
| Change in other assets and liabilities of cip-Variable Interest Entity Primary Beneficiaryand Voting Interest Entity | -3,599 | -2,744 | -1,623 | 2,359 |
| Amortization of discount on notes payable of cip-Variable Interest Entity Primary Beneficiaryand Voting Interest Entity | NaN | 3,450 | 0 | 0 |
| Net cash provided by (used in) operating activities | 35,901 | -247,444 | 108,275 | 71,970 |
| Purchase of equity method investment | NaN | 41,084 | NaN | NaN |
| Change in cash and cash equivalents of cip due to consolidation (deconsolidation), net-Variable Interest Entity Primary Beneficiaryand Voting Interest Entity | NaN | 113 | 0 | 522 |
| Capital expenditures | 2,360 | 944 | 1,412 | 4,534 |
| Acquisition of business, net of cash acquired of 2.7 million | 196,110 | 0 | NaN | NaN |
| Net cash provided by (used in) investing activities | -198,470 | -41,915 | -1,412 | -4,012 |
| Borrowings on credit agreement | 50,000 | 201,191 | NaN | NaN |
| Repayments on credit agreement | 1,000 | 1,000 | 37,879 | 1,375 |
| Refinancing of credit agreement | NaN | NaN | -201,191 | NaN |
| Payment of deferred financing costs | NaN | 234 | 7,132 | NaN |
| Common stock dividends paid | 17,897 | 16,273 | 15,359 | 32,967 |
| Repurchase of common shares | 10,000 | 9,999 | 0 | 50,000 |
| Payment of contingent consideration | 22,621 | 0 | 0 | 23,140 |
| Taxes paid related to net share settlement of restricted stock units | 5,138 | 208 | 674 | 6,965 |
| Investment management subsidiary equity sales (purchases) | 0 | 9,040 | 14,796 | 1,053 |
| Net contributions from (distributions to) noncontrolling interests | -13,195 | 889 | -5,801 | 15,300 |
| Payments on borrowings by cip | 390,294 | 319,989 | 7,271 | 126,325 |
| Borrowings by cip | 369,246 | 661,125 | 0 | 0 |
| Net cash provided by (used in) financing activities | -40,899 | 305,271 | 112,279 | -226,525 |
| Effect of exchange rate changes on cash, cash equivalents and restricted cash | -278 | 31 | -235 | 1,594 |
| Net increase (decrease) in cash, cash equivalents and restricted cash | -203,746 | 15,943 | 218,907 | -156,973 |
| Cash, cash equivalents and restricted cash, beginning of period | 478,186 | 462,243 | 400,309 | NaN |
| Cash, cash equivalents and restricted cash, end of period | 274,440 | 478,186 | 462,243 | NaN |
VIRTUS INVESTMENT PARTNERS, INC. (VRTS)
VIRTUS INVESTMENT PARTNERS, INC. (VRTS)